Elagolix
RxNorm 2049846
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2049846 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: elagolix.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Elagolix
(Atom ID: 10287349)
PTPrescribable
Designated preferred name (PT):
Elagolix
(Atom ID: 10802008)
FNPrescribable
Full form of descriptor (FN):
Elagolix (substance)
(Atom ID: 10802009)
PTPrescribable
Designated preferred name (PT):
Elagolix-containing product
(Atom ID: 10802012)
FNPrescribable
Full form of descriptor (FN):
Product containing elagolix (medicinal product)
(Atom ID: 10810853)
Patient Education
Elagolix
Elagolix is used to manage pain due to endometriosis (a condition in which the type of tissue that lines the uterus [womb] grows in other areas of the body and causes infertility, pain before and during menstrual periods, pain during and after sexual activity, and heavy or irregular bleeding). Elagolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of certain hormones in the body.
[Learn More]
* Please review the disclaimer below.